Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters










Database
Language
Publication year range
1.
Clin Dev Immunol ; 2011: 370872, 2011.
Article in English | MEDLINE | ID: mdl-21461372

ABSTRACT

Dengue virus infection can lead to dengue fever (DF) or dengue hemorrhagic fever (DHF). Disease severity has been linked to an increase in various cytokine levels. In this study, we evaluated the effectiveness of doxycycline and tetracycline to modulate serum levels of IL-6, IL-1B, and TNF and cytokine receptor/receptor antagonist TNF-R1 and IL-1RA in patients with DF or DHF. Hospitalized patients were randomized to receive standard supportive care or supportive care combined with doxycycline or tetracycline therapy. Serum cytokine and cytokine receptor/antagonist levels were determined at the onset of therapy and after 3 and 7 days. Cytokine and cytokine receptor/antagonist levels were substantially elevated at day 0. IL-6, IL-1ß, and TNF remained at or above day 0 levels throughout the study period in untreated patients. Treatment with tetracycline or doxycycline resulted in a significant decline in cytokine levels. Similarly, IL-1RA and TNF-R1 serum concentrations were elevated at baseline and showed a moderate increase among untreated patients. Both drugs resulted in a significant rise in IL-1Ra levels by day 3 in patients. In contrast, treatment did not affect a similar result for TNF-R1. When compared to the control group, however, a significant rise post-treatment was seen upon intragroup analysis. Further analysis demonstrated that doxycycline was significantly more effective at modulating cytokine and cytokine receptor/antagonist levels than tetracycline.


Subject(s)
Doxycycline/administration & dosage , Severe Dengue/drug therapy , Severe Dengue/immunology , Tetracycline/administration & dosage , Adolescent , Adult , Child , Doxycycline/therapeutic use , Enzyme-Linked Immunosorbent Assay , Female , Humans , Interleukin 1 Receptor Antagonist Protein/blood , Interleukin 1 Receptor Antagonist Protein/immunology , Interleukin-1beta/blood , Interleukin-1beta/immunology , Interleukin-6/blood , Interleukin-6/immunology , Male , Middle Aged , Receptors, Tumor Necrosis Factor/blood , Receptors, Tumor Necrosis Factor/immunology , Severe Dengue/blood , Severe Dengue/physiopathology , Severity of Illness Index , Tetracycline/therapeutic use , Treatment Outcome , Tumor Necrosis Factor-alpha/blood , Tumor Necrosis Factor-alpha/immunology , Young Adult
2.
Vector Borne Zoonotic Dis ; 9(2): 209-12, 2009 Apr.
Article in English | MEDLINE | ID: mdl-18945189

ABSTRACT

Canine ehrlichiosis is a disease produced by the rickettsial organism Ehrlichia canis. Reported prevalence may vary greatly depending on the test and sampling method used. For the serological detection of antibodies against E. canis, the indirect immunofluorescence antibody test (IFA) is considered the gold standard. However, other available serological techniques such as the indirect immunoperoxidase technique (IPT) have not yet been tested and may be efficient in detecting specific antibodies. Prevalence found (8.7% and 8.1% for IFA and IPT, respectively) was lower than previously reported in the studied area despite the well-established technique used for the determination of antigens. A kappa value of 0.958 (95% CI 0.9-1.0) was found with a sensitivity and specificity for IPT of 92.59% (95% CI 80.8-99.9) and 99.9% (95% CI 99.8 -100), respectively. The positive predictive value was 99.9% and the negative predictive value was 99.29%. The IPT technique can be used safely for serological determination of E. canis antibodies.


Subject(s)
Antibodies, Bacterial/blood , Dog Diseases/diagnosis , Dog Diseases/epidemiology , Ehrlichia canis/isolation & purification , Ehrlichiosis/veterinary , Immunoenzyme Techniques/veterinary , Animals , Dog Diseases/microbiology , Dogs , Ehrlichia canis/immunology , Ehrlichiosis/diagnosis , Ehrlichiosis/epidemiology , Female , Fluorescent Antibody Technique, Indirect/veterinary , Immunoenzyme Techniques/standards , Male , Mexico/epidemiology , Sensitivity and Specificity , Seroepidemiologic Studies
SELECTION OF CITATIONS
SEARCH DETAIL
...